Skip to main content
Fig. 6 | Diabetology & Metabolic Syndrome

Fig. 6

From: Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness

Fig. 6

Effects of placebo and chloroquine on potential mechanistic mediators. a Activated JNK in circulating monocytes at baseline and 12 months. *P = 0.0164; P = 0.3343 for placebo; paired t tests. b Plasma concentrations of the oxysterol cholestane-3β, 5α, 6β-triol at 12 months. *P = 0.0031; unpaired t test

Back to article page